Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection.
Michael Grimley, Gabriela Maron, Carlos A Gomez, Vinod K. Prasad, Jasmeen Dara, Genovefa A Papanicolaou, Koji Fukushima, Robert F. Wynn, Michael Boeckh
